Skip to main content

Seelos Therapeutics Inc. Common Stock (SEEL)

About The Company

SEEL Stock Market Logo

Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System (“CNS”) disorders and other rare disorders.

IPO Year Sector Industry
N/A Health Care Biotechnology: Pharmaceutical Preparations

Seelos Therapeutics Inc. (SEEL) Latest News

Company Contact & Address (SEEL)

Corporate Headquarters Phone Website
300 PARK AVENUE 12TH FLOOR,
NEW YORK,
New York,
10022,
United States
+1 646 293-2100 Official SEEL Website

SEEL Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ SEEL

Jobs & Employment at Seelos Therapeutics Inc.

LinkedIn Company Page https://www.linkedin.com/company/seelos
Official Career & Employment Page Employment, Careers & Jobs at Seelos Therapeutics Inc. (SEEL)

Related & Similar Stock Symbols

NKSH Stock Market Price & News

NKSH

National Bankshares Inc. Common Stock

AGX Stock Market Price & News

AGX

Argan Inc. Common Stock

ROCC Stock Market Price & News

ROCC

Ranger Oil Corporation Class A Common Stock